Rise and shine, everyone, the middle of the week is already here. Time moves quickly, yes? Of course, this is good reason to hang in there, since the end of the week cannot be too far away. Besides, what are the alternatives? And do you really want to know? Meanwhile, we are digging in for another busy day of foraging. So time to get cracking. Hope you have a simply smashing day and conquer the world. Meanwhile, here are some tidbits. Good luck. …

Drug makers saturated the country with 76 billion opioid pills from 2006 through 2012, the Washington Post writes, citing newly disclosed data from a Drug Enforcement Administration database released as part of the opioid litigation. Just six companies distributed 75% of the pills: McKesson (MCK) (MCK), Walgreens (WBA), Cardinal Health (CAH), AmerisourceBergen (ABC), CVS (CVS), and Walmart (WMT). Three companies manufactured 88% of the opioids: SpecGx, a unit of Mallinckrodt (MNK); ­Actavis Pharma, which is now part of Teva Pharmaceuticals (TEVA); and Par Pharmaceutical, a subsidiary of Endo Pharmaceuticals (ENDP).

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy